Morphological changes and nuclear translocation of DLC1 tumor suppressor protein precede apoptosis in human non-small cell lung carcinoma cells

Experimental Cell Research

Volumn 313, Issue 18, 2007, Pages 3868-3880

  Yuan, Bao Zhu ^a   Jefferson, Amy M ^a   Millecchia, Lyndell ^a   Popescu, Nicholas C ^b   Reynolds, Steven H ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; DLC1; Morphology; NSCLC; Protein nuclear translocation

Indexed keywords

ACTIN; CASPASE 3; DLC1 PROTEIN; SERINE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; DELETED IN LIVER CANCER 1 GENE; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TRANSPORT; TUMOR GENE;

EID: 35248890380     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.08.009     Document Type: Article

References (37)

1. Yuan B.Z., Miller M.J., Keck C.L., Zimonjic D.B., Thorgeirsson S.S., and Popescu N.C. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC1) homologous to rat RhoGAP. Cancer Res. 58 (1998) 2196-2199
2. Yuan B.Z., Jefferson A.M., Baldwin K.T., Thorgeirsson S.S., Popescu N.C., and Reynolds S.H. DLC1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene 23 (2004) 1405-1411
3. Yuan B.Z., Durkin M.E., and Popescu N.C. Promoter hypermethylation of DLC1, a candidate tumor suppressor gene, in several common human cancers. Cancer Genet. Cytogenet. 140 (2003) 113-117
4. Yuan B.Z., Zhou X., Durkin M.E., Zimonjic D.B., Gumundsdottir K., Eyfjord J.E., Thorgeirsson S.S., and Popescu N.C. DLC1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity. Oncogene 22 (2003) 445-450
5. Kim T.Y., Jong H.S., Song S.H., Dimtchev A., Jeong S.J., Lee J.W., Kim N.K., Jung M., and Bang Y.J. Transcriptional silencing of the DLC1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Oncogene 22 (2003) 3943-3951
6. Plaumann M., Seitz S., Frege R., Estevez-Schwarz L., and Scherneck S. Analysis of DLC1 expression in human breast cancer. J. Cancer Res. Clin. Oncol. 129 (2003) 349-354
7. Pang J.C., Chang Q., Chung Y.F., Teo J.G., Poon W.S., Zhou L.F., Kong X., and Ng H.K. Epigenetic inactivation of DLC1 in supratentorial primitive neuroectodermal tumor. Human Pathol. 36 (2005) 36-43
8. Guan M., Zhou X., Soulitzis N., Spandidos D.A., and Popescu N.C. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications. Clin. Cancer Res. 12 (2006) 1412-1419
9. Seng T.J., Low J.S., Li H., Cui Y., Goh H.K., Wong M.L., Srivastava G., Sidransky D., Califano J., Steenbergen R.D., Rha S.Y., Tan J., Hsieh W.S., Ambinder R.F., Lin X., Chan A.T., and Tao Q. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Oncogene 25 (2006)
10. Shi H., Guo J., Duff D.J., Rahmatpanah F., Chitima-Matsiga R., Al-Kuhlani M., Taylor K.H., Sjahputera O., Andreski M., Wooldridge J.E., and Caldwell C.W. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma. Carcinogenesis 28 (2007) 60-70
11. Ng I.O., Liang Z.D., Cao L., and Lee T.K. DLC1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC1. Cancer Res. 60 (2000) 6581-6584
12. Wong C.M., Yam J.W., Ching Y.P., Yau T.O., Leung T.H., Jin D.Y., and Ng I.O. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. Cancer Res. 65 (2005) 8861-8868
13. Zhou X., Thorgeirsson S.S., and Popescu N.C. Restoration of DLC1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene 23 (2004) 1308-1313
14. Goodison S., Yuan J., Sloan D., Kim R., Li C., Popescu N.C., and Urquidi V. The RhoGAP protein DLC1 functions as a metastasis suppressor in breast cancer cells. Cancer Res. 65 (2005) 6042-6053
15. Jemal A., Chu K.C., and Tarone R.E. Recent trends in lung cancer mortality in the United States. J. Natl. Cancer Inst. 93 (2001) 277-283
16. Steenland K., Loomis D., Shy C., and Simonsen N. Review of occupational lung carcinogens. Am. J. Ind. Med. 29 (1996) 474-490
17. Ullmannova V., and Popescu N.C. Expression profile of the tumor suppressor genes DLC1 and DLC-2 in solid tumors. Int. J. Oncol. 29 (2006) 1127-1132
18. Durkin M.E., Avner M.R., Huh C.G., Yuan B.Z., Thorgeirsson S.S., and Popescu N.C. DLC1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development. FEBS Lett. 579 (2005) 1191-1196
19. Homma Y., and Emori Y. A dual functional signal mediator showing RhoGAP and phospholipase C-delta stimulating activities. EMBO J. 14 (1995) 286-291
20. Boettner B., and Van Aelst L. The role of Rho GTPases in disease development. Gene 286 (2002) 155-174
21. Hall A. Rho GTPases and the actin cytoskeleton. Science 279 (1998) 509-514
22. Price L.S., and Collard J.G. Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion. Semin. Cancer Biol. 11 (2001) 167-173
23. Pruitt K., and Der C.J. Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett. 171 (2001) 1-10
24. Ridley A.J. Rho family proteins: coordinating cell responses. Trends Cell Biol. 11 (2001) 471-477
25. Sahai E., and Marshall C.J. RHO-GTPases and cancer. Nat. Rev., Cancer 2 (2002) 133-142
26. Hermeking H. The 14-3-3 cancer connection. Nat. Rev., Cancer 3 (2003) 931-943
27. Yuan B.Z., Jefferson A.M., and Reynolds S.H. DLC1 exerts its suppressive effect through the specific inhibition of Cdc42-mediated cell growth promotion in human NCI-H358 lung adenocarcinoma cell line. 95th AACR Annual Meeting, Orlando, Florida (2004)
28. Hacker G. The morphology of apoptosis. Cell Tissue Res. 301 (2000) 5-17
29. Sekimata M., Kabuyama Y., Emori Y., and Homma Y. Morphological changes and detachment of adherent cells induced by p122, a GTPase-activating protein for Rho. J. Biol. Chem. 274 (1999) 17757-17762
30. Gorlich D., and Mattaj I.W. Nucleocytoplasmic transport. Science 271 (1996) 1513-1518
31. Anastasiadis P.Z., Moon S.Y., Thoreson M.A., Mariner D.J., Crawford H.C., Zheng Y., and Reynolds A.B. Inhibition of RhoA by p120 catenin. Nat. Cell Biol. 2 (2000) 637-44.32
32. Yamazaki Y., Tsuruga M., Zhou D., Fujita Y., Shang X., Dang Y., Kawasaki K., and Oka S. Cytoskeletal disruption accelerates caspase-3 activation and alters the intracellular membrane reorganization in DNA damage-induced apoptosis. Exp. Cell Res. 259 (2000) 64-78
33. Kayalar C., Ord T., Testa M.P., Zhong L.T., and Bredesen D.E. Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2234-2238
34. Fennell D.A. Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploitation. Clin. Cancer Res. 11 (2005) 2097-2105
35. Minakhina S., Myers R., Druzhinina M., and Steward R. Crosstalk between the actin cytoskeleton and Ran-mediated nuclear transport. BMC Cell Biol. 6 (2005) 1-11
36. Hers I., Wherlock M., Homma Y., Yagisawa H., and Tavare J.M. Identification of p122RhoGAP (deleted in liver cancer-1) Serine 322 as a substrate for protein kinase B and ribosomal S6 kinase in insulin-stimulated cells. J. Biol. Chem. 281 (2006) 4762-4770
37. Manzoli L., Martelli A.M., Billi A.M., Faenza I., Fiume R., and Cocco L. Nuclear phospholipase C: Involvement in signal transduction. Prog. Lipid Res. 44 (2005) 185-206